Mallinckrodt plc

Damastown Industrial Estate, Mulhuddart,
Dublin, 15
+353 1 880 8180

Mallinckrodt is a specialty pharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company’s core strengths include the acquisition and management of highly regulated raw materials; deep regulatory expertise; and specialized chemistry, formulation and manufacturing capabilities.

M&A Summary

Buy vs Sell

Year ≤ '13 '14 '15 '16 '17 '18 T
Buy (1.8/yr) # 2 2 3 1 3 - 11
vol $175M $7.1B $3.8B $1.2B $12.3B
Sell (0.8/yr) # 1 - 1 1 1 1 5
vol $270M $690M $171M $1.1B

Top M&A Advisors

Financial Deals
Sign-up to View
Sign-up to View
Sign-up to View
Legal Deals
Sign-up to View
Sign-up to View

Deal Values

> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Questcor Pharmaceuticals, Inc.
$5.8B (2014-08-14)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View
Largest Mallinckrodt - Nuclear Imaging Business
$690M (2016-08-24)

According to our data here at Mergr, Mallinckrodt has acquired 13 companies, including 11 in the last 5 years. A total of 5 acquisitions came from private equity firms. It has also divested 5 assets.

Mallinckrodt’s largest acquisition to date was in 2014, when it acquired Questcor Pharmaceuticals for $5.8B. It’s largest disclosed sale occurred in 2016, when it sold Mallinckrodt - Nuclear Imaging Business to IBA Molecular Imaging for $690M. Mallinckrodt has acquired in 8 different US states. The Company’s most targeted sectors include life science (73%) and medical products (28%).

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 410 life science companies that have made at least 1 acquisition, 16 have acquired at least 5 companies, and 2 have acquired more than 10 companies. The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 29 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Ampersand Capital Partners with 5 platform acquisitions.

Join Mergr and gain access to Mallinckrodt’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.4K Private Equity Firms
  • 119K M&A Transactions
  • 129K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.